Escilabsp. z o.o.
Other research and experimental development on natural sciences and engineering
Overview
Escilab sp. z o.o. is carrying out a project to introduce the Escinea dietary supplement to the US market. The project involves developing an international expansion strategy and launching export sales in the United States, supported by EU funding of PLN 150,000.
Financials
Revenue history (in k)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 54 days late).
- 202515/07/2026
- 202411/07/2025
- 202303/07/2024
- 202209/07/2023
- 202107/09/2022
- 202001/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Escinea dietary supplement
- Natural substance research
- Research and development
Authorized Representatives
Manner of representation
In the case of a one-person management board, the sole member of the management board is authorized to submit declarations of will on behalf of the company independently, whereas in the case of a multi-member management board, each member of the management board is authorized to submit declarations of will on behalf of the company independently.
Ownership
| Owner | Share value | Stake |
|---|---|---|
Jakub Bilskiage 36 | $135,008.10 | 99.96% |
Others | $54.02 | 0.04% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Vewinsp. z o.o. | 6,753.11 USD | 50% |
Bank accounts
Registered as a VAT taxpayer on 2014-01-01.
55 1090 1870 0000 0001 2983 5467
Debt
No entries in the National Debtors Register (KRZ).
Public aid
5 public aid cases recorded, with a total value of $81,951.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 3, 2023 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $32,344$32,344 | Polska Agencja Inwestycji I Handlu S.A. | |
| Sep 9, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $2,417$2,417 | Mazowiecki Regionalny Fundusz Pożyczkowy sp. z o.o. | |
| Nov 26, 2019 | Aid for SMEs for innovation support | $27,346$27,346 | Prezes Polskiej Agencji Rozwoju Przedsiębiorczości |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2018-10-05 | Obtaining patent protection for a plant composition that suppresses appetite | $29,060$29,060 | Operational Programme Smart Growth | |
| 2016-12-01 | New Escinea - improvement of a dietary supplement | $18,972$18,972 | Regional Operational Programme for the Mazowieckie Voivodeship for 2014-2020 |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Countess Laboratoriessp. z o.o. | $99,221.13 | countess.pl |
Change history
| Date | Event | |
|---|---|---|
| 2020-12-17 | PKD change (Removed: 9 codes; Added: 9 codes) | |
| 2019-03-20 | Share capital increase (5,000.00 PLN → 500,000.00 PLN) | |
| 2019-01-11 | Address change (Ul. Duchnicka 3, 01-796, Warszawa → Ul. Bukowa 15, 02-708, Warszawa) | |
| 2015-03-17 | PKD change (Removed: 9 codes; Added: 5 codes) | |
| 2014-12-22 | Address change (Powązkowska 13b, 01-797, Warszawa → Ul. Duchnicka 3, 01-796, Warszawa) |
FAQ
Last updated: 2026-07-15